Latest Capital Management News

SPC Global reported a 27% rise in normalised EBITDA for FY26 to $38.5 million, supported by a $100 million equity raise that halved net leverage. The company’s strategic pivot to higher-margin branded products and operational efficiencies set the stage for targeted double-digit revenue and EBITDA growth in FY27.

Kyron Capital Group (ASX: KYN) reported a $51.9 million net loss for FY26, completing a $125 million recapitalisation to stabilise its balance sheet and reduce gearing. The Group's assets under management shrank to $1.8 billion following strategic divestments and mandate exits.

Kip McGrath Education Centres reversed prior losses with a $2.5 million profit in FY26 despite a 4.3% revenue dip driven by franchise consolidation and foreign exchange headwinds. The company declared a special dividend and faces an unsolicited $0.73 per share takeover offer.

CleanSpace Holdings is set to repurchase up to 10% of its shares over the next year, signalling confidence in its growth prospects and capital position.

Ashley Services Group delivered a standout FY26 with revenue up 16.7% to $602.2 million and net profit after tax surging 189.5% to $6.29 million, supported by margin gains across key sectors and a strategic acquisition.

Immuron Limited posted a 6% rise in FY26 sales to $7.7 million, improved its net loss by $1.4 million, and secured FDA approval for IMM-529, underpinning a strategic pivot towards profitability and geographic expansion.

PEXA Group delivered a solid FY26 with 7% revenue growth and a return to profitability, while facing a regulatory pricing review that could reshape its future investment capacity.

Westgold Resources delivered a landmark FY26 with record gold output, soaring profits, and a strong balance sheet underpinning a 10 cents per share fully franked dividend.

ECS Botanics boosted revenue by 10% to $21.4 million in FY26, delivering positive EBITDA and operating cash flow while advancing international market entry and branded product growth.

Austral Gold nearly doubled its gold equivalent production in the first half of 2026, driven by the Casposo restart and Guanaco operations, delivering a US$15.5 million net profit and extending Guanaco’s mine life to 14 years.

Saluda Medical delivered FY26 revenue of US$90.2 million, beating guidance with strong US and international growth, while reporting a flat net loss of US$149.6 million amid ongoing heavy investment. The company’s FDA approval of its CAP24 paddle lead opens a new US surgical market segment.

St Barbara Limited's FY26 statutory profit surged to A$490 million, driven by a A$500 million gain from deconsolidating New Simberi Gold after Lingbao's strategic investment. The company declared a fully franked dividend and is weighing a significant share buy-back while advancing key gold projects.